The functionality of ERα in ovarian cancer cells has been demonstrated using ovarian cancer cell line models, wherein the requirement of a moderate to a high level of ERα expression for a growth response to 17β-estradiol (E2) and anti-estrogens has been shown both in vitro [32,33,34] and in vivo [35]. Here, ESR1 is linked to ovarian carcinoma.